• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page


Replies
91
Views
29K
Replies
18
Views
7K
Replies
51
Views
7K
Replies
5
Views
858
Replies
6
Views
542